Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Maribavir

EU orphan designation number: EU/3/07/519   
Active ingredient: Maribavir
Indication: Prevention of cytomegalovirus (CMV) disease in patients with impaired cell mediated immunity deemed at risk
Sponsor: Shire Pharmaceuticals Ireland Limited
5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/12/2007 Orphan designation EMEA/OD/067/07 (2007)6799 of 18/12/2007
21/07/2008 Change of name and/or address of sponsor EMEA/OD/067/07
21/07/2008 Change of name and/or address of sponsor
24/02/2009 Transfer of orphan designation EMEA/OD/067/07/T/01 (2009)1274 of 20/02/2009
18/12/2009 Change of name and/or address of sponsor
17/03/2011 Change of name and/or address of sponsor EMEA/OD/067/07
19/02/2016 Change of name and/or address of sponsor
18/03/2016 Transfer of orphan designation EMA/OD/067/07/T/02 (2016)1713 of 15/03/2016